Hepatitis C Education and Testing Project RFA # 6341

 
The purpose of the CDPHE Request for Application (RFA) is to solicit responses to support the delivery of HCV system mobilization, outreach, and education services consistent with CDPHE's legislative mandate.
 
Goal 1 - Identify specific public health departments, health care professionals, public institutions, and community organizations that are already engaged in HCV screening and prevention, or are well-positioned to implement such services (based on the epidemiology of HCV in their client base or surrounding communities).
 
Goal 2 - Promote and coordinate HCV screening and prevention services among public health departments, health care professionals, public institutions, and community organizations, including support to:
  1. Identify high risk populations,
  2. Implement model screening processes and
  3. Make referrals or otherwise link people living with HCV to treatment;
Goal 3 - Provide education and outreach to the public, which must include:
  1. Basic information about the prevalence, transmission, risks, care, and treatment of HCV,
  2. Information about co-infection with HCV and the implications of co-infection for other similarly transmitted diseases,
  3. Information about HCV screening services available in the community, and
  4. Stimulation of interest among community-based organizations to sponsor HCV community forums and to undertake other appropriate community outreach activities.
Funding from this RFA may be used to support multiple public information strategies, including print media, radio, television, video, telephone hotlines, and the internet; these strategies should be coordinated with national public education efforts. Funding from this RFA may be used to support multiple public information strategies, including print media, radio, television, video, telephone hotlines, and the internet; these strategies should be coordinated with national public education efforts. 
 
Goal 4 - Provide HCV testing, which must include:
  1. Targeting and recruiting people who inject drugs (PWID), the population at greatest risk of HCV infection in Colorado;
  2. Using only FDA-approved testing technology and meeting other requirements for quality assurance, as described in the HCV Prevention Standards of Practice;
  3. Actively linking people who test positive for HCV to confirmatory testing and to HCV care resources;
  4. Actively linking people who test negative for HCV to prevention services, particularly syringe support programs
Application submission deadline: 05/18/17
 
Attachment A:         Request for Applications Cover Sheet and Signature Page
Attachment B:         Application Pre-Award Risk Assessment Questionnaire
Attachment B1:       Subrecipient Frequently Asked Questions
Attachment C:         Disclosure and Documentation
Attachment D:         W9
Attachment E:         HCV Prevention Standards
Attachment F:         Target Population Description
Attachment G:         SOW Work Plan Table Template
Attachment H:         Budget and Budget Justification
Attachment I:          General Provisions and Special Provisions-Contract
Attachment J:         Data Reporting for HIV and HCV Prevention